Arcutis Biotherapeutics, Inc. · NASDAQ:ARQT

Burnett Patrick sold 955 Arcutis Biotherapeutics, Inc. shares (Form 4)

Traded Aug 3, 2026 · Filed Aug 5, 2026

On Aug 3, 2026, Burnett Patrick (See Remarks) sold 955 Arcutis Biotherapeutics, Inc. shares at US$26.12 for US$24,945 under a trading plan, leaving 119,289 shares. Filed Aug 5, 2026 (Form 4).

Sold
955 shares
Price
US$26.12
Value
US$24,945
Holding after
119,289 shares
Trading plan
Yes (Made under a plan set in advance)
Role
See Remarks

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 3, 2026Common StockSale955US$26.12119,289Direct

Source

View original at SEC

Related